We are live on ! Find out more
MDCO

Medicines Co
MDCO

Delisted

MDCO was delisted on the 3rd of January, 2020.

Back to rankings

188 hedge funds and large institutions have $1.85B invested in Medicines Co in 2018 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 78 increasing their positions, 46 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

70% more repeat investments, than reductions

Existing positions increased: 78 | Existing positions reduced: 46

11% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 38

2% more funds holding

Funds holding: 184 → 188 (+4)

21% less call options, than puts

Call options by funds: $43.2M | Put options by funds: $54.4M

33% less funds holding in top 10

Funds holding in top 10: 9 → 6 (-3)

35% less capital invested

Capital invested by funds: $2.83B → $1.85B (-$981M)

Holders
188
Holders Change
+4
Holders Change %
+2.17%
% of All Funds
4.19%
Holding in Top 10
6
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-33.33%
% of All Funds
0.13%
New
42
Increased
78
Reduced
46
Closed
38
Calls
$43.2M
Puts
$54.4M
Net Calls
-$11.2M
Net Calls Change
-$2.54M

Top Buyers

Rank Fund Capital Flow
1
HM
HealthCor Management
New York
+$50.9M
2
MC
Maverick Capital
Texas
+$50M
3
IAM
Iridian Asset Management
Connecticut
+$33M
4
SCM
Sarissa Capital Management
Connecticut
+$20M
5
Bank of America
Bank of America
North Carolina
+$19.1M

Top Sellers

Rank Fund Capital Flow
1
PC
PointState Capital
New York
-$87.6M
2
PHS
PFM Health Sciences
California
-$76.6M
3
BC
Boxer Capital
California
-$27.2M
4
LPC
Lion Point Capital
New York
-$21.8M
5
O
OppenheimerFunds
New York
-$21.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$218M +$8.04M +345,721 +3%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$212M +$247K +10,597 +0.1%
Wellington Management Group
3
Wellington Management Group
Massachusetts
$197M -$12.3K -530 -0%
Vanguard Group
4
Vanguard Group
Pennsylvania
$131M +$4.15M +178,265 +3%
Westfield Capital Management
5
Westfield Capital Management
Massachusetts
$88.1M +$19M +817,508 +22%
AH
6
Aviva Holdings
Bahamas
$72.3M – – –
MC
7
Maverick Capital
Texas
$67.3M +$50M +2,150,140 +158%
IAM
8
Iridian Asset Management
Connecticut
$63.1M +$33M +1,417,229 +75%
BM
9
Bridger Management
New York
$58.6M +$16.8M +720,981 +31%
HM
10
HealthCor Management
New York
$55M +$50.9M +2,189,083 +321%
SCM
11
Sarissa Capital Management
Connecticut
$53.2M +$20M +859,000 +45%
State Street
12
State Street
Massachusetts
$43M +$881K +37,886 +2%
SPC
13
Slate Path Capital
New York
$39.7M +$1.86M +80,000 +4%
Macquarie Group
14
Macquarie Group
Australia
$39.5M +$11.7M +502,279 +32%
CCM
15
Camber Capital Management
Massachusetts
$38.3M – – –
PI
16
Putnam Investments
Massachusetts
$34.6M -$1.47M -63,236 -3%
Bank of America
17
Bank of America
North Carolina
$32.6M +$19.1M +821,162 +93%
GC
18
Greenlight Capital
New York
$18.2M – – –
Northern Trust
19
Northern Trust
Illinois
$16.4M -$1.82M -78,286 -8%
Geode Capital Management
20
Geode Capital Management
Massachusetts
$15.1M +$1.63M +70,001 +10%
Bank of New York Mellon
21
Bank of New York Mellon
New York
$15M +$309K +13,303 +2%
ECP
22
Elk Creek Partners
Colorado
$14.6M +$3.93M +168,802 +28%
RSCM
23
Rock Springs Capital Management
Maryland
$13.9M +$858K +36,900 +5%
Ameriprise
24
Ameriprise
Minnesota
$13.7M -$864K -37,132 -5%
PA
25
Pinnacle Associates
New York
$13.7M -$2.39M -102,792 -13%
1
2 3 4 5

MDCO Hedge Fund Activity: Q4 2018 in Review

188 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Medicines Co (MDCO) for Q4 2018, worth a combined $1.85B — down 35% from $2.83B a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new MDCO positions and 38 closed out — a net gain of 4 holders — while 78 added to existing stakes and 46 trimmed.

The largest buyer was HealthCor Management, adding an estimated $50.9M. The largest seller was PointState Capital, exiting entirely with an estimated $87.6M sold.

  • 188 institutional investors held Medicines Co (MDCO) as of Q4 2018, up from 184 in Q3 2018.
  • Funds reported $1.85B of Medicines Co stock for Q4 2018, down 35% quarter-over-quarter.
  • 42 funds opened new Medicines Co positions in Q4 2018 and 38 closed out, a net change of +4 holders.
  • The largest Medicines Co buyer in Q4 2018 was HealthCor Management, an estimated $50.9M added.
  • The largest Medicines Co seller in Q4 2018 was PointState Capital, an estimated $87.6M sold.

Based on aggregated 13F filings for Q4 2018.